Status
Conditions
Treatments
About
Medtronic is sponsoring and funding the AFFIX study, a prospective, post-market, multicenter, nonrandomized, single-arm, interventional clinical study. The purpose of this study is to evaluate the performance and safety of the MaxTack™ Motorized Fixation Device when used for fixation of prosthetic material to soft tissue in minimally invasive ventral hernia repair procedures.
Full description
A prospective, post-market, multicenter, nonrandomized, single-arm, interventional clinical study of the MaxTack™ Motorized Fixation Device when used for fixation of prosthetic material to soft tissue in minimally invasive ventral hernia repair procedures. Subjects will be followed in the short term (1 and 3 months) and long term (12 months) to evaluate safety and performance of the device.
The study is being conducted in two phases. Phase 1 will enroll approximately 33 subjects at up to 3 sites in the United States. Based on regulatory needs, Phase 2 may enroll additional subjects at approximately 10 US sites, for a total of up to 110 subjects across both phases.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Preoperative Inclusion Criteria:
Preoperative Exclusion Criteria:
Intraoperative Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
110 participants in 1 patient group
Loading...
Central trial contact
Alyssa Sutch, M.S.; Marion Blanc, PharmD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal